Yes. Thanks, Bill. And I think you're absolutely right in the observation around the spot market, right? We've seen a fairly steady decline in pricing as we've gone through the balance of the year, winding up this quarter at about $4,150 on a weighted average basis across all the geographies. I would say that needle coke prices have remained relatively consistent over that time. We're still in the, call it, $1,000 to $1,300 range depending on grades and jurisdiction for needle coke. So we've seen a little bit of a floor or at least a price support level on the needle coke side, but you're still seeing some slide on the electrode side. Some of that's timing related, right, as contracts are negotiated and delivered as we go through the quarter. But yes, still a tough pricing environment. But certainly, I think as we look forward, again, for all of the reasons that we've stated, whether that pricing turns immediately or if it takes a little bit of time, we do anticipate a rebound both in needle coke pricing as demand picks up for needle coke, which again then has a knock-on effect and will drive up electrode pricing. I think as you look at the industry more broadly, and I commented that a healthy steel industry needs a healthy electrode industry. Pricing in many of the jurisdictions we're seeing right now, I would not describe as healthy or sustainable for any of the key players in this market. So at some point in time, either companies will continue to take action, whether that's announced supply reductions, which we've talked about our announcement back in Q1, we talked about others' announcements in Q2 or you'll see pricing actions, which again, we've seen some pricing announcement here by competitors in the market more recently. So those actions will have to take place to balance out the market because otherwise, you won't have a healthy market to underpin all of the demand growth for steel going forward.